Amedeo Smart

Free Medical Literature Service




  Free Subscription


1 Acad Emerg Med
1 Am J Obstet Gynecol
3 Am J Respir Crit Care Med
3 Ann Intern Med
3 Antiviral Res
13 BMJ
1 Br J Anaesth
1 Clin Chem
9 Clin Infect Dis
3 Emerg Infect Dis
2 Infect Control Hosp Epidemiol
6 Int J Infect Dis
3 Intensive Care Med
10 J Infect
11 J Med Virol
3 J Travel Med
1 J Virol
16 Lancet
3 Lancet Infect Dis
5 MMWR Morb Mortal Wkly Rep
4 N Engl J Med
10 Nature
3 Radiology
2 Science

    Acad Emerg Med

    All the Death We Cannot See.
    Acad Emerg Med. 2021 Aug 10. doi: 10.1111/acem.14372.
    >> Share

    Am J Obstet Gynecol

  2. ROBERTS DJ, Edlow AG, Romero RJ, Coyne CB, et al
    SPECIAL REPORT: A standardized definition of placental infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a consensus statement from the National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health an
    Am J Obstet Gynecol. 2021 Aug 5. pii: S0002-9378(21)00832.
    >> Share

    Am J Respir Crit Care Med

    Fewer Bronchiectasis Exacerbations During the "Lockdown" for COVID-19: Can We Convert Knowledge into Action?
    Am J Respir Crit Care Med. 2021 Aug 12. doi: 10.1164/rccm.202107-1731.
    >> Share

  4. LEVY D, Lebreton G, Pineton de Chambrun M, Hekimian G, et al
    Outcomes of Patients Denied ECMO During the COVID-19 Pandemic in Greater Paris, France.
    Am J Respir Crit Care Med. 2021 Aug 10. doi: 10.1164/rccm.202105-1312.
    >> Share

  5. BING R, Andrews JP, Williams MC, van Beek EJR, et al
    In vivo Thrombosis Imaging in Patients Recovering from COVID-19 and Pulmonary Embolism.
    Am J Respir Crit Care Med. 2021 Aug 10. doi: 10.1164/rccm.202011-4182.
    >> Share

    Ann Intern Med

  6. GARG S, Patel K, Pham H, Whitaker M, et al
    Clinical Trends Among U.S. Adults Hospitalized With COVID-19, March to December 2020 : A Cross-Sectional Study.
    Ann Intern Med. 2021 Aug 10. doi: 10.7326/M21-1991.
    >> Share

  7. CENTOR RM, Klompas M, Pearson M, Morris C, et al
    Annals On Call - The Case for Mandating COVID-19 Vaccines for Health Care Workers.
    Ann Intern Med. 2021 Aug 10:OC1. doi: 10.7326/A20-0020.
    >> Share

  8. BRETTHAUER M, Helsingen LM, Loberg M, Kalager M, et al
    Evidence and Precaution for Legal Health Interventions: Learning From the COVID-19 Pandemic.
    Ann Intern Med. 2021 Aug 10. doi: 10.7326/M21-2839.
    >> Share

    Antiviral Res

  9. ISON MG, Hayden FG, Hay AJ, Gubareva LV, et al
    Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group.
    Antiviral Res. 2021;194:105158.
    >> Share

  10. LEACH A, Ilca FT, Akbar Z, Ferrari M, et al
    A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency.
    Antiviral Res. 2021 Aug 7:105147. doi: 10.1016/j.antiviral.2021.105147.
    >> Share

  11. ESCAFFRE O, Freiberg AN
    Polyphenylene carboxymethylene (PPCM) microbicide repurposed as antiviral against SARS-CoV-2. Proof of concept in primary human undifferentiated epithelial cells.
    Antiviral Res. 2021 Aug 9:105162. doi: 10.1016/j.antiviral.2021.105162.
    >> Share


  12. DAVIDSON SL, Menkes DB
    Long covid: reshaping conversations about medically unexplained symptoms.
    BMJ. 2021;374:n1859.
    >> Share

    Chronic fatigue syndrome and long covid: individualisation, not compartmentalisation.
    BMJ. 2021;374:n1863.
    >> Share

  14. FLOURIS AD, Babar Z, Ioannou LG, Onarheim KH, et al
    Improving the evidence on health inequities in migrant construction workers preparing for big sporting events.
    BMJ. 2021;374:n1615.
    >> Share

  15. ONARHEIM KH, Phua KH, Babar ZR, Flouris AD, et al
    Health and social needs of migrant construction workers for big sporting events.
    BMJ. 2021;374:n1591.
    >> Share

    Covid-19: Junior doctors write to young people to acknowledge vaccine concerns.
    BMJ. 2021;374:n1963.
    >> Share

  17. MAJEED A
    Longitudinal data on covid-19 immunity could be collected from medical records.
    BMJ. 2021;374:n1976.
    >> Share

  18. SHEMTOB L, Ferris M, Asanati K, Majeed A, et al
    Vaccinating healthcare workers against covid-19.
    BMJ. 2021;374:n1975.
    >> Share

    Covid-19: Charity offers scholarships to bereaved children of healthcare staff.
    BMJ. 2021;374:n1989.
    >> Share

  20. CHUNG A, Tully L, Czernin S, Thompson R, et al
    Reducing risk of childhood obesity in the wake of covid-19.
    BMJ. 2021;374:n1716.
    >> Share

    Covid-19: How effective are vaccines against the delta variant?
    BMJ. 2021;374:n1960.
    >> Share

  22. WASSWA H
    Covid-19: Uganda's low inpatient numbers mask high community infection as desperate patients turn to herbs.
    BMJ. 2021;374:n1909.
    >> Share

  23. STOCKL H, Quigg Z
    Violence against women and girls.
    BMJ. 2021;374:n1926.
    >> Share

  24. O'DOWD A
    Covid-19: Schools are not hubs of infection and are safe to reopen after summer break, study shows.
    BMJ. 2021;374:n2008.
    >> Share

    Br J Anaesth

  25. FERRANDIS R, Llau JV, Afshari A, Douketis JD, et al
    Management of perioperative thromboprophylaxis for surgery following COVID-19: an expert-panel survey.
    Br J Anaesth. 2021 Jul 9. pii: S0007-0912(21)00435.
    >> Share

    Clin Chem

  26. CHEN H, Li Z, Feng S, Richard-Greenblatt M, et al
    Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Tracking.
    Clin Chem. 2021 Aug 12. pii: 6349222. doi: 10.1093.
    >> Share

    Clin Infect Dis

  27. DIMEGLIO C, Herin F, Da-Silva I, Jougla I, et al
    Heterologous ChAdOx1-S/BNT162b2 vaccination: neutralizing antibody response to SARS-CoV-2.
    Clin Infect Dis. 2021 Aug 12. pii: 6349304. doi: 10.1093.
    >> Share

  28. CERAMI C, Popkin-Hall ZR, Rapp T, Tompkins K, et al
    Household transmission of SARS-CoV-2 in the United States: living density, viral load, and disproportionate impact on communities of color.
    Clin Infect Dis. 2021 Aug 12. pii: 6349288. doi: 10.1093.
    >> Share

  29. CALDERON-PARRA J, Munez-Rubio E, Fernandez-Cruz A, Garcia Sanchez MC, et al
    Incidence, clinical presentation, relapses and outcome of SARS-CoV-2 infection in patients treated with anti-CD20 monoclonal antibodies.
    Clin Infect Dis. 2021 Aug 12. pii: 6348942. doi: 10.1093.
    >> Share

  30. PAULES CI, Gallagher SK, Rapaka RR, Davey RT, et al
    Remdesivir for the prevention of invasive mechanical ventilation or death in COVID-19 - A post-hoc analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data.
    Clin Infect Dis. 2021 Aug 11. pii: 6348134. doi: 10.1093.
    >> Share

  31. JACOBS JL, Bain W, Naqvi A, Staines B, et al
    SARS-CoV-2 Viremia is Associated with COVID-19 Severity and Predicts Clinical Outcomes.
    Clin Infect Dis. 2021 Aug 10. pii: 6347519. doi: 10.1093.
    >> Share

  32. CLIPMAN SJ, Wesolowski A, Mehta SH, Cobey S, et al
    Improvements in SARS-CoV-2 Testing Cascade in the US: Data from Serial Cross-sectional Assessments.
    Clin Infect Dis. 2021 Aug 10. pii: 6347429. doi: 10.1093.
    >> Share

  33. BAKER MA, Sands KE, Huang SS, Kleinman K, et al
    The Impact of COVID-19 on Healthcare-Associated Infections.
    Clin Infect Dis. 2021 Aug 9. pii: 6346721. doi: 10.1093.
    >> Share

  34. NORTH CM, Barczak A, Goldstein RH, Healy BC, et al
    Determining the Incidence of Asymptomatic SARS-CoV-2 among Early Recipients of COVID-19 Vaccines: A Prospective Cohort Study of Healthcare Workers before, during and after Vaccination [DISCOVER-COVID-19].
    Clin Infect Dis. 2021 Aug 7. pii: 6345339. doi: 10.1093.
    >> Share

  35. GIL E, Martyn E, Rokadiya S, Jain S, et al
    Bacterial Coinfection in COVID-19.
    Clin Infect Dis. 2021;73:e843-e845.
    >> Share

    Emerg Infect Dis

  36. UJIIE M, Tsuzuki S, Nakamoto T, Iwamoto N, et al
    Resurgence of Respiratory Syncytial Virus Infections during COVID-19 Pandemic, Tokyo, Japan.
    Emerg Infect Dis. 2021;27.
    >> Share

  37. HOGAN CA, Jassem AN, Sbihi H, Joffres Y, et al
    Rapid Increase in SARS-CoV-2 P.1 Lineage Leading to Codominance with B.1.1.7 Lineage, British Columbia, Canada, January-April 2021.
    Emerg Infect Dis. 2021;27.
    >> Share

  38. MAISON-FOMOTAR M, Sivasubramanian G
    Bordetella hinzii Pneumonia and Bacteremia in a Patient with SARS-CoV-2 Infection.
    Emerg Infect Dis. 2021;27.
    >> Share

    Infect Control Hosp Epidemiol

  39. WILKINS JT, Hirschhorn LR, Gray EL, Wallia A, et al
    Serologic Status and SARS CoV-2 Infection over 6-Months of Follow-Up in Healthcare Workers in Chicago: A Cohort Study.
    Infect Control Hosp Epidemiol. 2021 Aug 9:1-29. doi: 10.1017/ice.2021.
    >> Share

  40. GUBBAY JB, Rilkoff H, Kristjanson HL, Forbes JD, et al
    Impact of COVID-19 pre-test probability on positive predictive value of high cycle threshold SARS-CoV-2 real-time reverse transcription PCR test results.
    Infect Control Hosp Epidemiol. 2021 Aug 9:1-18. doi: 10.1017/ice.2021.
    >> Share

    Int J Infect Dis

  41. JACOB L, Koyanagi A, Smith L, Haro JM, et al
    Prevalence of and factors associated with COVID-19 diagnosis in symptomatic patients followed in general practices in Germany between March 2020 and March 2021.
    Int J Infect Dis. 2021 Aug 8. pii: S1201-9712(21)00642.
    >> Share

  42. PIMENOFF VN, Bjornstedt M, Dillner J
    Severe features during outbreak but low mortality observed immediately before and after a March-May Covid-19 outbreak in Stockholm, Sweden.: Mortality before, during and after a COVID-19 outbreak.
    Int J Infect Dis. 2021 Aug 7. pii: S1201-9712(21)00637.
    >> Share

  43. SAEED BQ, Al-Shahrabi R, Alhaj SS, Alkokhardi ZM, et al
    Side Effects and Perceptions Following Sinopharm COVID-19 Vaccination.
    Int J Infect Dis. 2021 Aug 9. pii: S1201-9712(21)00646.
    >> Share

  44. NAKAMURA Y, Katano H, Nakajima N, Sato Y, et al
    SARS-CoV-2 is localized in cardiomyocytes: a post-mortem biopsy case.
    Int J Infect Dis. 2021 Aug 9. pii: S1201-9712(21)00647.
    >> Share

  45. DIAZ-AROCUTIPA C, Melgar-Talavera B, Alvarado-Yarasca A, Saravia-Bartra MM, et al
    Statins reduce mortality in patients with COVID-19: an updated meta-analysis of 147,824 patients.
    Int J Infect Dis. 2021 Aug 7. pii: S1201-9712(21)00636.
    >> Share

  46. BUTT AA, Nafady-Hego H, Chemaitelly H, Abou-Samra AB, et al
    Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination: Breakthrough SARS-CoV-2 infection.
    Int J Infect Dis. 2021 Aug 7. pii: S1201-9712(21)00639.
    >> Share

    Intensive Care Med

  47. ARABI YM, Derde LPG, Timsit JF
    How COVID-19 will change the management of other respiratory viral infections.
    Intensive Care Med. 2021 Aug 11. pii: 10.1007/s00134-021-06491.
    >> Share

  48. RODRIGUEZ-RUIZ E, Campelo-Izquierdo M, Estany-Gestal A, Rodriguez-Nunez A, et al
    Impact of different visiting policies on family satisfaction in two Spanish ICUs before and during COVID-19.
    Intensive Care Med. 2021 Aug 7. pii: 10.1007/s00134-021-06485.
    >> Share

  49. ZANELLA A, Florio G, Antonelli M, Bellani G, et al
    Time course of risk factors associated with mortality of 1260 critically ill patients with COVID-19 admitted to 24 Italian intensive care units.
    Intensive Care Med. 2021 Aug 9. pii: 10.1007/s00134-021-06495.
    >> Share

    J Infect

  50. YAHI N, Chahinian H, Fantini J
    Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination ?
    J Infect. 2021 Aug 9. pii: S0163-4453(21)00392.
    >> Share

  51. ALLEN N, Brady M, Martin AIC, Domegan L, et al
    Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals.
    J Infect. 2021 Aug 9. pii: S0163-4453(21)00394.
    >> Share

  52. KHAN MI, Qureshi H, Khattak AA, Awan UA, et al
    Predicting COVID-19 incidence in Pakistan: It's time to act now!
    J Infect. 2021 Aug 9. pii: S0163-4453(21)00393.
    >> Share

    Post-COVID Functional Limitations on Daily Living Activities are Associated with Symptoms Experienced at the Acute Phase of SARS-CoV-2 Infection and Internal Care Unit Admission: A Multicenter Study.
    J Infect. 2021 Aug 7. pii: S0163-4453(21)00391.
    >> Share

  54. TANNER AR, Phan H, Brendish NJ, Borca F, et al
    SARS-CoV-2 Viral load at presentation to hospital is independently associated with the risk of death.
    J Infect. 2021 Aug 4. pii: S0163-4453(21)00384.
    >> Share

  55. LIM SY, Kim JY, Lee JA, Kwon JS, et al
    Immune responses and reactogenicity after ChAdOx1 in individuals with past SARS-CoV-2 infection and those without.
    J Infect. 2021 Jul 28. pii: S0163-4453(21)00375.
    >> Share

  56. Predominance of Delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021.
    J Infect. 2021 Aug 5. pii: S0163-4453(21)00387.
    >> Share

  57. LAMB G, Heskin J, Randell P, Mughal N, et al
    Real-world evaluation of COVID-19 lateral flow device (LFD) mass-testing in healthcare workers at a London hospital; a prospective cohort analysis.
    J Infect. 2021 Aug 5. pii: S0163-4453(21)00383.
    >> Share

  58. GOBBI F, Buonfrate D, Silva R, Martini D, et al
    Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine: SARS-CoV-2 infection early after the first vaccine dose.
    J Infect. 2021 Aug 6. pii: S0163-4453(21)00390.
    >> Share

  59. Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals.
    J Infect. 2021 Aug 6. pii: S0163-4453(21)00388.
    >> Share

    J Med Virol

  60. KUNO T, So M, Miyamoto Y, Iwagami M, et al
    The association of COVID-19 antibody with in-hospital outcomes in COVID-19 infected patients.
    J Med Virol. 2021 Aug 9. doi: 10.1002/jmv.27260.
    >> Share

  61. PADILLA-ROJAS C, Jimenez-Vasquez V, Hurtado V, Mestanza O, et al
    Genomic analysis reveals a rapid spread and predominance of Lambda (C.37) SARS-COV-2 lineage in Peru despite circulation of variants of concern.
    J Med Virol. 2021 Aug 9. doi: 10.1002/jmv.27261.
    >> Share

  62. ABBASS S, Salama M, Salman T, Sabry A, et al
    fficacy and safety of Sofosbuvir plus Daclatasvir or Ravidasvir in patients with COVID-19, A Randomized Controlled Trial.
    J Med Virol. 2021 Aug 11. doi: 10.1002/jmv.27264.
    >> Share

  63. CHI G, Memar Montazerin S, Lee JJ, Kazmi SHA, et al
    Effect of Azithromycin and Hydroxychloroquine in Patients Hospitalized with COVID-19: Network Meta-Analysis of Randomized Controlled Trials.
    J Med Virol. 2021 Aug 9. doi: 10.1002/jmv.27259.
    >> Share

    Antibody response to SARS-CoV-2 vaccination, previous SARS-CoV-2 infection and change to single dose vaccination.
    J Med Virol. 2021 Aug 10. doi: 10.1002/jmv.27263.
    >> Share

  65. CICCOZZI M, Maruotti A, Ceccarelli G, Divino F, et al
    While we are discussing...the SARS-CoV-2 virus laughs.
    J Med Virol. 2021 Aug 10. doi: 10.1002/jmv.27266.
    >> Share

  66. STRUCK F, Schreiner P, Staschik E, Wochinz-Richter K, et al
    Vaccination versus infection with SARS-CoV-2: Establishment of a high avidity IgG response versus incomplete avidity maturation.
    J Med Virol. 2021 Aug 13. doi: 10.1002/jmv.27270.
    >> Share

  67. DENG J, Heybati K, Zhou F
    Letter to the editor in response to "Safety and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis".
    J Med Virol. 2021 Aug 13. doi: 10.1002/jmv.27269.
    >> Share

  68. FARI G, de Sire A, Giorgio V, Rizzo L, et al
    Impact of COVID-19 on the mental health in a cohort of Italian Rehabilitation health care workers.
    J Med Virol. 2021 Aug 13. doi: 10.1002/jmv.27272.
    >> Share

  69. YILMAZ G, Ebru O, Ibrahim B, Ulkem C, et al
    J Med Virol. 2021 Aug 13. doi: 10.1002/jmv.27271.
    >> Share

  70. ZHOU R, Liu L, Wang Y
    Viral Proteins Recognized by Different TLRs.
    J Med Virol. 2021 Aug 10. doi: 10.1002/jmv.27265.
    >> Share

    J Travel Med

  71. KLINGER C, Burns J, Movsisyan A, Biallas R, et al
    Unintended health and societal consequences of international travel measures during the COVID-19 pandemic: A scoping review.
    J Travel Med. 2021 Aug 9. pii: 6346387. doi: 10.1093.
    >> Share

  72. SAMMITO S, Muller GPJ, Erley OM, Werner A, et al
    Impact of in-flight use of FFP2 masks on oxygen saturation: an experimental crossover study.
    J Travel Med. 2021;28.
    >> Share

  73. LIU Y, Rocklov J
    The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus.
    J Travel Med. 2021 Aug 9. pii: 6346388. doi: 10.1093.
    >> Share

    J Virol

  74. LU M, Zhang Y, Dravid P, Li A, et al
    A methyltransferase-defective VSV-based SARS-CoV-2 vaccine candidate provides complete protection against SARS-CoV-2 infection in hamsters.
    J Virol. 2021 Aug 11:JVI0059221. doi: 10.1128/JVI.00592.
    >> Share


  75. ABBASI J
    Antigen Testing Every 3 Days Is Highly Sensitive for SARS-CoV-2.
    JAMA. 2021;326:473.
    >> Share

  76. KADRI SS, Simpson SQ
    Potential Implications of SARS-CoV-2 Delta Variant Surges for Rural Areas and Hospitals.
    JAMA. 2021 Aug 12. pii: 2783233. doi: 10.1001/jama.2021.13941.
    >> Share

  77. ABBASI J
    Oldest Adults Need 2 mRNA Vaccine Doses to Neutralize SARS-CoV-2.
    JAMA. 2021;326:473.
    >> Share

  78. LAURING AS, Malani PN
    Variants of SARS-CoV-2.
    JAMA. 2021 Aug 13. pii: 2783248. doi: 10.1001/jama.2021.14181.
    >> Share

  79. CONGRAVE-WILSON Z, Lee Y, Jumarang J, Perez S, et al
    Change in Saliva RT-PCR Sensitivity Over the Course of SARS-CoV-2 Infection.
    JAMA. 2021 Aug 13. pii: 2783249. doi: 10.1001/jama.2021.13967.
    >> Share

  80. ABBASI J
    COVID-19 mRNA Vaccines Blunt Breakthrough Infection Severity.
    JAMA. 2021;326:473.
    >> Share


  81. PUNG R, Mak TM, Kucharski AJ, Lee VJ, et al
    Serial intervals in SARS-CoV-2 B.1.617.2 variant cases.
    Lancet. 2021 Aug 10. pii: S0140-6736(21)01697.
    >> Share

  82. BLACK C
    Treatment for drug dependence in England needs investment and reform.
    Lancet. 2021;398:474-476.
    >> Share

  83. CHAUHAN K, Soni D, Sarkar D, Karuna T, et al
    Mucormycosis after COVID-19 in a patient with diabetes.
    Lancet. 2021 Aug 4. pii: S0140-6736(21)01641.
    >> Share

  84. EMANUEL EJ, Buchanan A, Chan SY, Fabre C, et al
    What are the obligations of pharmaceutical companies in a global health emergency?
    Lancet. 2021 Aug 5. pii: S0140-6736(21)01378.
    >> Share

  85. PEYRE M, Vourc'h G, Lefrancois T, Martin-Prevel Y, et al
    PREZODE: preventing zoonotic disease emergence.
    Lancet. 2021;397:792-793.
    >> Share

  86. DEVI S
    Mediterranean migrants lacking health care.
    Lancet. 2021;398:479-480.
    >> Share

  87. LEE N
    Lucy Chappell: setting the agenda for UK research policy.
    Lancet. 2021;398:481.
    >> Share

  88. DOLEZAL L, Rose A, Cooper F
    COVID-19, online shaming, and health-care professionals.
    Lancet. 2021;398:482-483.
    >> Share

  89. PISANI L, Waweru-Siika W, Sendagire C, Beane A, et al
    Critically ill COVID-19 patients in Africa: it is time for quality registry data.
    Lancet. 2021;398:485-486.
    >> Share

  90. BICCARD BM, Thomson D, Miller M, Taylor EH, et al
    Critically ill COVID-19 patients in Africa: it is time for quality registry data - Authors' reply.
    Lancet. 2021;398:486-487.
    >> Share

  91. LIU X, Shaw RH, Stuart ASV, Greenland M, et al
    Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
    Lancet. 2021 Aug 6. pii: S0140-6736(21)01694.
    >> Share

    Optimising SARS-CoV-2 vaccination schedules.
    Lancet. 2021 Aug 6. pii: S0140-6736(21)01729.
    >> Share

  93. MANGIN D, Howard M
    The use of inhaled corticosteroids in early-stage COVID-19.
    Lancet. 2021 Aug 10. pii: S0140-6736(21)01809.
    >> Share

  94. PRIESEMANN V, Balling R, Bauer S, Beutels P, et al
    Towards a European strategy to address the COVID-19 pandemic.
    Lancet. 2021 Aug 9. pii: S0140-6736(21)01808.
    >> Share

  95. PERRY RJ, Tamborska A, Singh B, Craven B, et al
    Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study.
    Lancet. 2021 Aug 6. pii: S0140-6736(21)01608.
    >> Share

  96. YU LM, Bafadhel M, Dorward J, Hayward G, et al
    Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
    Lancet. 2021 Aug 10. pii: S0140-6736(21)01744.
    >> Share

    Lancet Infect Dis

  97. TSANG NNY, So HC, Ip DKM
    Is oropharyngeal sampling a reliable test to detect SARS-CoV-2? - Authors' reply.
    Lancet Infect Dis. 2021 Aug 4. pii: S1473-3099(21)00402.
    >> Share

  98. TODSEN T, Kirkby N, Benfield T
    Is oropharyngeal sampling a reliable test to detect SARS-CoV-2?
    Lancet Infect Dis. 2021 Aug 4. pii: S1473-3099(21)00395.
    >> Share

  99. KADAMBARI S, Vanderslott S
    Lessons about COVID-19 vaccine hesitancy among minority ethnic people in the UK.
    Lancet Infect Dis. 2021 Aug 9. pii: S1473-3099(21)00404.
    >> Share

    MMWR Morb Mortal Wkly Rep

  100. MOLINE HL, Whitaker M, Deng L, Rhodes JC, et al
    Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged >/=65 Years - COVID-NET, 13 States, February-April 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1088-1093.
    >> Share

  101. YOON P, Hall J, Fuld J, Mattocks SL, et al
    Alternative Methods for Grouping Race and Ethnicity to Monitor COVID-19 Outcomes and Vaccination Coverage.
    MMWR Morb Mortal Wkly Rep. 2021;70:1075-1080.
    >> Share

  102. ROSENBLUM HG, Hadler SC, Moulia D, Shimabukuro TT, et al
    Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July
    MMWR Morb Mortal Wkly Rep. 2021;70:1094-1099.
    >> Share

  103. HERLIHY R, Bamberg W, Burakoff A, Alden N, et al
    Rapid Increase in Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - Mesa County, Colorado, April-June 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1084-1087.
    >> Share

  104. CAVANAUGH AM, Spicer KB, Thoroughman D, Glick C, et al
    Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination - Kentucky, May-June 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1081-1083.
    >> Share

    N Engl J Med

  105. GUIMARAES PO, Quirk D, Furtado RH, Maia LN, et al
    Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia.
    N Engl J Med. 2021;385:406-415.
    >> Share

  106. ALI K, Berman G, Zhou H, Deng W, et al
    Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents.
    N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMoa2109522.
    >> Share

  107. PAVORD S, Scully M, Hunt BJ, Lester W, et al
    Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
    N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMoa2109908.
    >> Share

  108. WILLIAMS WW, Ingelfinger JR
    Third Time's a Charm - Covid-19 Vaccine Hope for Solid-Organ Transplant Recipients.
    N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMe2112866.
    >> Share


  109. PADMA TV
    How COVID changed schools outreach.
    Nature. 2021;594:289-291.
    >> Share

    Mental health of graduate students sorely overlooked.
    Nature. 2021;595:135-137.
    >> Share

  111. COVID vaccine inequity, species swaps - the week in infographics.
    Nature. 2021 Aug 6. pii: 10.1038/d41586-021-02151.
    >> Share

  112. BAKER N, Reardon S
    Coronapod: Ivermectin, what the science says.
    Nature. 2021 Aug 6. pii: 10.1038/d41586-021-02178.
    >> Share

  113. KIDMAN R
    Use HIV's lessons to help children orphaned by COVID-19.
    Nature. 2021;596:185-188.
    >> Share

  114. DEAN N
    COVID vaccination studies: plan now to pool data, or be bogged down in confusion.
    Nature. 2021;591:179.
    >> Share

    Remember Beta? New data reveal variant's deadly powers.
    Nature. 2021 Aug 9. pii: 10.1038/d41586-021-02177.
    >> Share

    How do vaccinated people spread Delta? What the science says.
    Nature. 2021 Aug 12. pii: 10.1038/d41586-021-02187.
    >> Share

  117. MAXMEN A
    Chelsea Clinton urges global sharing of COVID vaccine technology.
    Nature. 2021 Aug 9. pii: 10.1038/d41586-021-02164.
    >> Share

  118. BRAGA A, Francioni V, Barra V, Falcone C, et al
    Call to update US re-entry rules for international researchers.
    Nature. 2021;596:189.
    >> Share


  119. KRAVCHENKO D, Isaak A, Zimmer S, Mesropyan N, et al
    Cardiac MRI in Patients with Prolonged Cardiorespiratory Symptoms after Mild to Moderate COVID-19 Infection.
    Radiology. 2021 Aug 10:211162. doi: 10.1148/radiol.2021211162.
    >> Share

  120. SOLOMON JJ, Heyman B, Ko JP, Condos R, et al
    CT of Postacute Lung Complications of COVID-19.
    Radiology. 2021 Aug 10:211396. doi: 10.1148/radiol.2021211396.
    >> Share

  121. LIMA JAC, Bluemke DA
    Myocardial Scar in COVID-19: Innocent Marker versus Harbinger of Clinical Disease.
    Radiology. 2021 Aug 10:211710. doi: 10.1148/radiol.2021211710.
    >> Share


    WHO relaunches global drug trial with three new candidates.
    Science. 2021;373:606-607.
    >> Share

  123. PEGU A, O'Connell S, Schmidt SD, O'Dell S, et al
    Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.
    Science. 2021 Aug 12. pii: science.abj4176. doi: 10.1126/science.abj4176.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016